Key result
Dystrophin mutations alter cardiac transcription and splicing distinct from skeletal muscle in X-linked dilated cardiomyopathy.
Why the study?
X linked dilated cardiomyopathy involves mutations in the dystrophin gene with differing expression patterns in cardiac versus skeletal muscle, highlighting tissue-specific pathogenic mechanisms.
Population
Families with X linked dilated cardiomyopathy
Design
Review of proposed pathogenetic mechanisms
Authors
Loading...
Tissue-specific splicing differences caution against skeletal-based assumptions in X-linked DCM; leaves open cardiac-selective therapeutic targeting.
This review highlights how tissue-specific processing of dystrophin gene mutations leads to X-linked dilated cardiomyopathy, distinguishing its cardiac effects from skeletal muscular dystrophies.
Niaz Cohen (2004) conducted a review in X linked dilated cardiomyopathy. Dystrophin gene mutations was evaluated. Dystrophin gene mutations in X-linked dilated cardiomyopathy affect transcription and splicing in a tissue-specific manner, highlighting differences between skeletal and cardiac tissues.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: